Hepatitis C, Chronic [clinicaltrials_resource:0fd1a99a08ed2ea914d6bad9cf276bd0]
Evaluating Silymarin for Chronic Hepatitis C [clinicaltrials:NCT00030030]ISIS 14803-CS2, Treatment With ISIS 14803, Administered IV in Patients With Chronic Hepatitis C Virus Infections [clinicaltrials:NCT00035945]clinicaltrials:NCT00039871Thymosin Plus PEG-Interferon in Hepatitis C Patients With Cirrhosis Who Did Not Respond to Interferon or Interferon Plus Ribavirin [clinicaltrials:NCT00039962]Thymosin Plus PEG-Interferon in Non-Cirrhotic Hepatitis C Patients Who Did Not Respond to Interferon or Interferon Plus Ribavirin [clinicaltrials:NCT00040027]IdB 1016 Treatment for Hepatitis C Disease [clinicaltrials:NCT00055445]Addition of ISIS 14803 to Therapy With Peginterferon and Ribavirin for Chronic Hepatitis C (HCV) Patients Not Responding Adequately to the Two Drugs [clinicaltrials:NCT00062816]ACCELERATE Study - A Study of PEGASYS (Peginterferon Alfa-2a (40KD)) in Combination With COPEGUS (Ribavirin) in Interferon-Naive Patients With Chronic Hepatitis C (CHC) Infection. [clinicaltrials:NCT00077636]A Study of PEGASYS (Peginterferon Alfa-2a (40KD)) in Combination With COPEGUS (Ribavirin) in Interferon-Naive Patients With Chronic Hepatitis C Infection (CHC). [clinicaltrials:NCT00077649]clinicaltrials:NCT00081770A Study of PEGASYS (Peginterferon Alfa-2a (40KD)) in Combination With Ribavirin in Patients With Chronic Hepatitis C (CHC) Previously Treated With PEG-Intron + Ribavirin [clinicaltrials:NCT00087568]A Study of PEGASYS (Peginterferon Alfa-2a (40KD)) in Combination With Copegus (Ribavirin) in Patients With Chronic Hepatitis C (CHC) Enrolled in a Methadone Maintenance Treatment Program. [clinicaltrials:NCT00087594]PEAK Study - A Study of PEGASYS (Peginterferon Alfa-2a (40KD)) in Combination With COPEGUS (Ribavirin) in Interferon-Naive Patients With Chronic Hepatitis C (CHC). [clinicaltrials:NCT00087607]clinicaltrials:NCT00087633REPEAT Study - A Study of PEGASYS (Peginterferon Alfa-2a (40KD)) Therapy in Combination With COPEGUS (Ribavirin) in Patients With Chronic Hepatitis C (CHC) Who Did Not Respond to Previous PegIntron (Peginterferon Alfa-2b (12KD))/Ribavirin Combination Therapy [clinicaltrials:NCT00087646]A Caspase Inhibitor in Chronic Hepatitis C (HCV) Patients [clinicaltrials:NCT00088140]clinicaltrials:NCT00104052Latino Study - A Study of PEGASYS (Peginterferon Alfa-2a (40KD)) and COPEGUS (Ribavirin) in Treatment-Naive Patients With Chronic Hepatitis C-Genotype 1. [clinicaltrials:NCT00107653]SB497115 (Oral Thrombopoietin Receptor Agonist) Versus Placebo In Adults With Thrombocytopenia Due To Hepatitis C [clinicaltrials:NCT00110799]A Study of Albuferon and Ribavirin in Interferon Naive Subjects With Chronic Hepatitis C Genotype 1 [clinicaltrials:NCT00115908]Efficacy and Safety of Pentoxyphilline and Tocopherol on the Fibrosis in Patients With Chronic Hepatitis C [clinicaltrials:NCT00119119]Efficacy of Pegylated Interferon on Liver Fibrosis in Co-infected Patient With HIV and Hepatitis C [clinicaltrials:NCT00122616]Triple Therapy With Peg-Interferon Alfa-2b/Ribavirin Plus Amantadine Compared to Standard Peg-Interferon Alfa-2b/Ribavirin for Previous Hepatitis C Virus (HCV) Non Responders [clinicaltrials:NCT00122629]Peginterferon Alfa-2a, Ribavirin, Amantadine/Placebo in Hepatitis C Virus (HCV)-Genotype-1-Infection (PRAMA) [clinicaltrials:NCT00127777]clinicaltrials:NCT00135694Efficacy of Prazosin Versus Placebo Associated With Peg-Interferon Alpha 2b and Ribavirin in Chronic Hepatitis C With Genotype 1 or 4 and Severe Fibrosis [clinicaltrials:NCT00148837]Interferon Gamma With Peg-Interferon Alpha 2a and Ribavirin in Non Responders Patients With Chronic Hepatitis C [clinicaltrials:NCT00148863]Peginterferon Alfa-2a Plus Ribavirin for Chronic Hepatitis C/Hepatitis B Co-Infection and Chronic Hepatitis C [clinicaltrials:NCT00154869]A Study to Evaluate the Safety and Efficacy of Celgosivir in Patients With Chronic Hepatitis C Genotype 1 Infection [clinicaltrials:NCT00157534]clinicaltrials:NCT00166296clinicaltrials:NCT00202839Comparative Trial of Standard Versus Low-Dose Peg-Interferon Plus Ribavirin in the Treatment of Chronic Hepatitis C [clinicaltrials:NCT00216775]A Study to Evaluate the Safety and Efficacy of Celgosivir and Peginterferon Alfa-2b, With or Without Ribavirin, in Patients With Chronic Hepatitis C Genotype 1 Infection [clinicaltrials:NCT00217139]Peginterferon Alfa-2a Plus Ribavirin Plus Amantadine for the Treatment of Hepatitis C Infected Patients [clinicaltrials:NCT00221624]Treatment of Chronic Hepatitis C With PEG Interferon alfa2a and Ribavirin in HIV-Infected Patients [clinicaltrials:NCT00221650]Long-Term Evaluation Follow-up of Neurocognitive Performance and Emotional State in Patients With Chronic Hepatitis C [clinicaltrials:NCT00227149]Effect of Infliximab on the Efficacy of Peg-Intron/Ribavirin in Patients With Hepatitis C (Study P04257AM4)(COMPLETED) [clinicaltrials:NCT00237484]clinicaltrials:NCT00255008clinicaltrials:NCT00255034clinicaltrials:NCT00265395
condition [clinicaltrials_vocabulary:condition]
Combination Drug Therapy for Patients With Hepatitis C [clinicaltrials:NCT00001729]Long-Term Therapy With Ribavirin for Chronic Hepatitis C [clinicaltrials:NCT00001854]clinicaltrials:NCT00006164clinicaltrials:NCT00028093Gamma Interferon Therapy for Chronic Hepatitis C [clinicaltrials:NCT00028275]Evaluating Silymarin for Chronic Hepatitis C [clinicaltrials:NCT00030030]ISIS 14803-CS2, Treatment With ISIS 14803, Administered IV in Patients With Chronic Hepatitis C Virus Infections [clinicaltrials:NCT00035945]clinicaltrials:NCT00039871Thymosin Plus PEG-Interferon in Hepatitis C Patients With Cirrhosis Who Did Not Respond to Interferon or Interferon Plus Ribavirin [clinicaltrials:NCT00039962]Thymosin Plus PEG-Interferon in Non-Cirrhotic Hepatitis C Patients Who Did Not Respond to Interferon or Interferon Plus Ribavirin [clinicaltrials:NCT00040027]Study of FK788 in Subjects With Chronic Hepatitis C Virus Infection [clinicaltrials:NCT00047814]clinicaltrials:NCT00048724clinicaltrials:NCT00049842IdB 1016 Treatment for Hepatitis C Disease [clinicaltrials:NCT00055445]clinicaltrials:NCT00056862Addition of ISIS 14803 to Therapy With Peginterferon and Ribavirin for Chronic Hepatitis C (HCV) Patients Not Responding Adequately to the Two Drugs [clinicaltrials:NCT00062816]ACCELERATE Study - A Study of PEGASYS (Peginterferon Alfa-2a (40KD)) in Combination With COPEGUS (Ribavirin) in Interferon-Naive Patients With Chronic Hepatitis C (CHC) Infection. [clinicaltrials:NCT00077636]A Study of PEGASYS (Peginterferon Alfa-2a (40KD)) in Combination With COPEGUS (Ribavirin) in Interferon-Naive Patients With Chronic Hepatitis C Infection (CHC). [clinicaltrials:NCT00077649]clinicaltrials:NCT00081770CIFN and IFN γ-1b With or Without Ribavirin for Treatment of Chronic Hepatitis C (Nonresponders) [clinicaltrials:NCT00084279]Daily-Dose Consensus Interferon and Ribavirin: Efficacy of Combined Therapy [clinicaltrials:NCT00086541]A Study of PEGASYS (Peginterferon Alfa-2a (40KD)) in Combination With Ribavirin in Patients With Chronic Hepatitis C (CHC) Previously Treated With PEG-Intron + Ribavirin [clinicaltrials:NCT00087568]A Study of PEGASYS (Peginterferon Alfa-2a (40KD)) in Combination With Copegus (Ribavirin) in Patients With Chronic Hepatitis C (CHC) Enrolled in a Methadone Maintenance Treatment Program. [clinicaltrials:NCT00087594]PEAK Study - A Study of PEGASYS (Peginterferon Alfa-2a (40KD)) in Combination With COPEGUS (Ribavirin) in Interferon-Naive Patients With Chronic Hepatitis C (CHC). [clinicaltrials:NCT00087607]clinicaltrials:NCT00087633REPEAT Study - A Study of PEGASYS (Peginterferon Alfa-2a (40KD)) Therapy in Combination With COPEGUS (Ribavirin) in Patients With Chronic Hepatitis C (CHC) Who Did Not Respond to Previous PegIntron (Peginterferon Alfa-2b (12KD))/Ribavirin Combination Therapy [clinicaltrials:NCT00087646]A Caspase Inhibitor in Chronic Hepatitis C (HCV) Patients [clinicaltrials:NCT00088140]Merimepodib (MMPD) in Triple Combination for the Treatment of Chronic Hepatitis C [clinicaltrials:NCT00088504]Study of Viramidine to Ribavirin in Patients With Chronic Hepatitis C Who Are Treatment Naive [clinicaltrials:NCT00093093]A Study of Albuferon With Ribavirin in Interferon Treatment Experienced Subjects With Chronic Hepatitis C [clinicaltrials:NCT00097435]clinicaltrials:NCT00100659clinicaltrials:NCT00104052Latino Study - A Study of PEGASYS (Peginterferon Alfa-2a (40KD)) and COPEGUS (Ribavirin) in Treatment-Naive Patients With Chronic Hepatitis C-Genotype 1. [clinicaltrials:NCT00107653]SB497115 (Oral Thrombopoietin Receptor Agonist) Versus Placebo In Adults With Thrombocytopenia Due To Hepatitis C [clinicaltrials:NCT00110799]A Study of Albuferon and Ribavirin in Interferon Naive Subjects With Chronic Hepatitis C Genotype 1 [clinicaltrials:NCT00115908]A Study to Evaluate the Combination of Pegylated Interferon Alfa Plus Valopicitabine in Patients With Hepatitis C [clinicaltrials:NCT00118768]Efficacy and Safety of Pentoxyphilline and Tocopherol on the Fibrosis in Patients With Chronic Hepatitis C [clinicaltrials:NCT00119119]Valopicitabine When Administered Alone and in Combination With Interferon to Treatment-Naive Patients With Hepatitis C [clinicaltrials:NCT00120835]Valopicitabine Alone and Together With Pegylated Interferon in Patients With Chronic Hepatitis C Who Have Failed to Respond to Standard Therapy [clinicaltrials:NCT00120861]Efficacy of Pegylated Interferon on Liver Fibrosis in Co-infected Patient With HIV and Hepatitis C [clinicaltrials:NCT00122616]
condition browse [clinicaltrials_vocabulary:condition-browse]
Combination Drug Therapy for Patients With Hepatitis C [clinicaltrials:NCT00001729]Long-Term Therapy With Ribavirin for Chronic Hepatitis C [clinicaltrials:NCT00001854]clinicaltrials:NCT00006164clinicaltrials:NCT00028093Gamma Interferon Therapy for Chronic Hepatitis C [clinicaltrials:NCT00028275]Evaluating Silymarin for Chronic Hepatitis C [clinicaltrials:NCT00030030]ISIS 14803-CS2, Treatment With ISIS 14803, Administered IV in Patients With Chronic Hepatitis C Virus Infections [clinicaltrials:NCT00035945]clinicaltrials:NCT00039871Thymosin Plus PEG-Interferon in Hepatitis C Patients With Cirrhosis Who Did Not Respond to Interferon or Interferon Plus Ribavirin [clinicaltrials:NCT00039962]Thymosin Plus PEG-Interferon in Non-Cirrhotic Hepatitis C Patients Who Did Not Respond to Interferon or Interferon Plus Ribavirin [clinicaltrials:NCT00040027]Study of FK788 in Subjects With Chronic Hepatitis C Virus Infection [clinicaltrials:NCT00047814]clinicaltrials:NCT00048724clinicaltrials:NCT00049842IdB 1016 Treatment for Hepatitis C Disease [clinicaltrials:NCT00055445]clinicaltrials:NCT00056862Addition of ISIS 14803 to Therapy With Peginterferon and Ribavirin for Chronic Hepatitis C (HCV) Patients Not Responding Adequately to the Two Drugs [clinicaltrials:NCT00062816]ACCELERATE Study - A Study of PEGASYS (Peginterferon Alfa-2a (40KD)) in Combination With COPEGUS (Ribavirin) in Interferon-Naive Patients With Chronic Hepatitis C (CHC) Infection. [clinicaltrials:NCT00077636]A Study of PEGASYS (Peginterferon Alfa-2a (40KD)) in Combination With COPEGUS (Ribavirin) in Interferon-Naive Patients With Chronic Hepatitis C Infection (CHC). [clinicaltrials:NCT00077649]clinicaltrials:NCT00081770CIFN and IFN γ-1b With or Without Ribavirin for Treatment of Chronic Hepatitis C (Nonresponders) [clinicaltrials:NCT00084279]Daily-Dose Consensus Interferon and Ribavirin: Efficacy of Combined Therapy [clinicaltrials:NCT00086541]A Study of PEGASYS (Peginterferon Alfa-2a (40KD)) in Combination With Ribavirin in Patients With Chronic Hepatitis C (CHC) Previously Treated With PEG-Intron + Ribavirin [clinicaltrials:NCT00087568]A Study of PEGASYS (Peginterferon Alfa-2a (40KD)) in Combination With Copegus (Ribavirin) in Patients With Chronic Hepatitis C (CHC) Enrolled in a Methadone Maintenance Treatment Program. [clinicaltrials:NCT00087594]PEAK Study - A Study of PEGASYS (Peginterferon Alfa-2a (40KD)) in Combination With COPEGUS (Ribavirin) in Interferon-Naive Patients With Chronic Hepatitis C (CHC). [clinicaltrials:NCT00087607]clinicaltrials:NCT00087633REPEAT Study - A Study of PEGASYS (Peginterferon Alfa-2a (40KD)) Therapy in Combination With COPEGUS (Ribavirin) in Patients With Chronic Hepatitis C (CHC) Who Did Not Respond to Previous PegIntron (Peginterferon Alfa-2b (12KD))/Ribavirin Combination Therapy [clinicaltrials:NCT00087646]A Caspase Inhibitor in Chronic Hepatitis C (HCV) Patients [clinicaltrials:NCT00088140]Merimepodib (MMPD) in Triple Combination for the Treatment of Chronic Hepatitis C [clinicaltrials:NCT00088504]Study of Viramidine to Ribavirin in Patients With Chronic Hepatitis C Who Are Treatment Naive [clinicaltrials:NCT00093093]A Study of Albuferon With Ribavirin in Interferon Treatment Experienced Subjects With Chronic Hepatitis C [clinicaltrials:NCT00097435]clinicaltrials:NCT00100659clinicaltrials:NCT00104052Latino Study - A Study of PEGASYS (Peginterferon Alfa-2a (40KD)) and COPEGUS (Ribavirin) in Treatment-Naive Patients With Chronic Hepatitis C-Genotype 1. [clinicaltrials:NCT00107653]SB497115 (Oral Thrombopoietin Receptor Agonist) Versus Placebo In Adults With Thrombocytopenia Due To Hepatitis C [clinicaltrials:NCT00110799]A Study of Albuferon and Ribavirin in Interferon Naive Subjects With Chronic Hepatitis C Genotype 1 [clinicaltrials:NCT00115908]A Study to Evaluate the Combination of Pegylated Interferon Alfa Plus Valopicitabine in Patients With Hepatitis C [clinicaltrials:NCT00118768]Efficacy and Safety of Pentoxyphilline and Tocopherol on the Fibrosis in Patients With Chronic Hepatitis C [clinicaltrials:NCT00119119]Valopicitabine When Administered Alone and in Combination With Interferon to Treatment-Naive Patients With Hepatitis C [clinicaltrials:NCT00120835]Valopicitabine Alone and Together With Pegylated Interferon in Patients With Chronic Hepatitis C Who Have Failed to Respond to Standard Therapy [clinicaltrials:NCT00120861]Efficacy of Pegylated Interferon on Liver Fibrosis in Co-infected Patient With HIV and Hepatitis C [clinicaltrials:NCT00122616]
condition mesh [clinicaltrials_vocabulary:condition-mesh]
Hepatitis C, Chronic [clinicaltrials_resource:0fd1a99a08ed2ea914d6bad9cf276bd0]
Bio2RDF identifier
0fd1a99a08ed2ea914d6bad9cf276bd0
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:0fd1a99a08ed2ea914d6bad9cf276bd0
identifier
clinicaltrials_resource:0fd1a99a08ed2ea914d6bad9cf276bd0
title
Hepatitis C, Chronic
@en
type
label
Hepatitis C, Chronic [clinicaltrials_resource:0fd1a99a08ed2ea914d6bad9cf276bd0]
@en
Hepatitis C, Chronic